Gregory Weitsman - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Gregory Weitsman

Showing results (21-30 of 24) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 24 results.

Science Signaling|March 27, 2014

Antagonism of EGFR and HER3 enhances the response to inhibitors of the PI3K-Akt pathway in triple-negative breast cancerJessica J Tao, Pau Castel, Nina Radosevic-Robin, et al.

Cell Reports|July 19, 2018

ALIX Regulates Tumor-Mediated Immunosuppression by Controlling EGFR Activity and PD-L1 PresentationJames Monypenny, Hanna Milewicz, Fabian Flores-Borja, et al.

EMBO Molecular Medicine|August 5, 2024

The MondoA-dependent TXNIP/GDF15 axis predicts oxaliplatin response in colorectal adenocarcinomasJinhai Deng, Teng Pan, Dan Wang, et al.

Cancer Discovery|March 28, 2020

HER2-Mediated Internalization of Cytotoxic Agents in <i>ERBB2</i> Amplified or Mutant Lung CancersBob T Li, Flavia Michelini, Sandra Misale, et al.

Pageof 3

Search research articles

Showing results (21-30 of 24) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 24 results.

Science Signaling|March 27, 2014

Antagonism of EGFR and HER3 enhances the response to inhibitors of the PI3K-Akt pathway in triple-negative breast cancerJessica J Tao, Pau Castel, Nina Radosevic-Robin, et al.

Cell Reports|July 19, 2018

ALIX Regulates Tumor-Mediated Immunosuppression by Controlling EGFR Activity and PD-L1 PresentationJames Monypenny, Hanna Milewicz, Fabian Flores-Borja, et al.

EMBO Molecular Medicine|August 5, 2024

The MondoA-dependent TXNIP/GDF15 axis predicts oxaliplatin response in colorectal adenocarcinomasJinhai Deng, Teng Pan, Dan Wang, et al.

Cancer Discovery|March 28, 2020

HER2-Mediated Internalization of Cytotoxic Agents in <i>ERBB2</i> Amplified or Mutant Lung CancersBob T Li, Flavia Michelini, Sandra Misale, et al.

Pageof 3